OBJECTIVE: To compare potentials of magnetic resonance imaging (MRI), F-18 FDG, and 11C-Choline PET/CT in differentiating brain tumor recurrence from necrosis after radiotherapy. METHODS: Fifty-five patients with suspected brain tumor recurrence or necrosis after radiotherapy underwent MRI, F-18 FDG, and 11C-choline PET/CT examinations, and all the patients were followed up for at least 11 months. Lesion diagnoses based on medical imaging were compared with pathology or follow-up outcomes. RESULTS: The sensitivities of MRI, F-18 FDG PET/CT, and 11C-Choline PET/CT in lesion diagnosis were 87.2%, 76.9%, and 92.3%, respectively, and their specificities were 81.3%, 62.5%, and 87.5%, respectively. CONCLUSION: The results suggest that 11C-Choline PET/CT with higher sensitivity and specificity may be better in distinguishing recurrent brain tumor from radionecrosis compared with F-18 FDG PET/CT and MRI.
OBJECTIVE: To compare potentials of magnetic resonance imaging (MRI), F-18 FDG, and 11C-Choline PET/CT in differentiating brain tumor recurrence from necrosis after radiotherapy. METHODS: Fifty-five patients with suspected brain tumor recurrence or necrosis after radiotherapy underwent MRI, F-18 FDG, and 11C-choline PET/CT examinations, and all the patients were followed up for at least 11 months. Lesion diagnoses based on medical imaging were compared with pathology or follow-up outcomes. RESULTS: The sensitivities of MRI, F-18 FDG PET/CT, and 11C-Choline PET/CT in lesion diagnosis were 87.2%, 76.9%, and 92.3%, respectively, and their specificities were 81.3%, 62.5%, and 87.5%, respectively. CONCLUSION: The results suggest that 11C-Choline PET/CT with higher sensitivity and specificity may be better in distinguishing recurrent brain tumor from radionecrosis compared with F-18 FDG PET/CT and MRI.
Authors: G Lai; A Mahadevan; D Hackney; P C Warnke; F Nigim; E Kasper; E T Wong; B S Carter; C C Chen Journal: AJNR Am J Neuroradiol Date: 2015-10-01 Impact factor: 3.825
Authors: N Tomura; Y Ito; H Matsuoka; T Saginoya; S-I Numazawa; Y Mizuno; K Watanabe Journal: AJNR Am J Neuroradiol Date: 2012-12-28 Impact factor: 3.825
Authors: Abigail L Stockham; Manmeet Ahluwalia; Chandana A Reddy; John H Suh; Aryavarta Kumar; Michael A Vogelbaum; Gene H Barnett; Erin S Murphy; Samuel T Chao Journal: J Neurooncol Date: 2013-09-18 Impact factor: 4.130
Authors: Jonathan E Leeman; David A Clump; John C Flickinger; Arlan H Mintz; Steven A Burton; Dwight E Heron Journal: Neuro Oncol Date: 2013-12 Impact factor: 12.300
Authors: David C Soler; Andrew B Young; Kevin D Cooper; Amber Kerstetter-Fogle; Jill S Barnholtz-Sloan; Haley Gittleman; Thomas S McCormick; Andrew E Sloan Journal: J Neurooncol Date: 2017-05-27 Impact factor: 4.130